Journals / Eurasian Journal of Pulmonology / 2018 / Cilt: 20 - Sayı: 2

The approach to community-acquired pneumonia: A survey study

Pages
93–98
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A total of 78 individuals responded to the questionnaire on the website.CONCLUSION: The responses to the questionnaire could indicate the way forward for newguidelines for physicians in respect of the approach to CAP.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION AND AIM: Community-acquired pneumonia (CAP), which is often seen in dailypractice, is a lower respiratory tract and pulmonary parenchyma infection which develops in societyand daily life with community-acquired pathogens in individuals with no known immune failure.
📊
Key Findings & Data:Delayin the treatment of pneumonia is known to increase morbidity and mortality.
💡
Conclusion & Impact:A total of 78 individuals responded to the questionnaire on the website.CONCLUSION: The responses to the questionnaire could indicate the way forward for newguidelines for physicians in respect of the approach to CAP.
🔬Design:Survey & Empirical Study
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION AND AIM: Community-acquired pneumonia (CAP), which is often seen in dailypractice, is a lower respiratory tract and pulmonary parenchyma infection which develops in societyand daily life with community-acquired pathogens in individuals with no known immune failure. Delayin the treatment of pneumonia is known to increase morbidity and mortality. Various scoring systemsare currently used in the identification of treatment groups in pneumonia. With the aim of evaluatingthe approach to CAP cases, the infection.MATERIALS AND METHODS: Working Group of the Turkish Respiratory ResearchAssociation (TUSAD) prepared a 22-item questionnaire.RESULTS: The survey was published on the TUSAD official website between July 2013 and June2016. A total of 78 individuals responded to the questionnaire on the website.CONCLUSION: The responses to the questionnaire could indicate the way forward for newguidelines for physicians in respect of the approach to CAP.

🔖

Cite This Article

Sen, N., Aydemir, Y., Ozyurek, B. A., Alizoroglu, D., Erturk, A., Ozhan, M. H. (2022). The approach to community-acquired pneumonia: A survey study. Eurasian Journal of Pulmonology, Cilt: 20 - Sayı: 2, 93–98. https://ajindex.com/articles/509692

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bulbul Y. Community-Acquired Pneumonia Data in Turkey, Current Chest Disease Series 2014;2:1-10
  2. Guest JF, Morris A. Community‑acquired pneumonia: The annual cost to the national health service in the UK. Eur Respir J 1997;10:1530‑4
  3. Türkiye İstatistik Kurumu. Sağlık İstatistikleri; 2004. Available from: http://www.tuik.gov.tr. [Last accessed on 2017 Dec 16]
  4. Sintes H, Sibila O, Waterer GW, Chalmers JD. Severity assesment tools in CAP. Eur Respir Monogr 2014;63:88‑104
  5. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community‑acquired pneumonia. Arch Intern Med 2004;164:637‑44
  6. Musher DM, Roig IL, Cazares G, Stager CE, Logan N, Safar H, et al. Can an etiologic agent be identified in adults who are hospitalized for community‑acquired pneumonia: Results of a one‑year study. J Infect 2013;67:11‑8
  7. Gwatkin DR. Acute respiratory infections in under‑fives: 15 million deaths a year. Lancet 1985;2:699‑701
  8. Pio A, Leowski J Luelmo F. Epidemiological magnitude of the problem of acute respiratory infections in children in developing countries. Bull IUAT 1983;58:199
  9. Centers for Disease Control and Prevention. Introduction to table V. Premature deaths, monthly mortality, and monthly physician contacts – United States. MMWR Morb Mortal Wkly Rep 1997;46:556‑61
  10. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, et al. Trends in infectious diseases mortality in the United States. JAMA 1996;275:189‑93
  11. Marston BJ, Plouffe JF, File TM Jr., Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community‑acquired pneumonia requiring hospitalization. Results of a population‑based active surveillance study in Ohio. The Community‑Based Pneumonia İncidence Study Group. Arch Intern Med 1997;157:1709‑18
  12. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community‑acquired pneumonia. Clin Ther 1998;20:820‑37
  13. T. C. Ministry of Health. Refik Saydam Hygiene Center Presidency Hıfzıssıhha School Directorate, Başkent University National Disease Burden and Cost Efficiency Project 2004. Available from: http://www.toraks.org.tr. [Last accessed on 2017 Dec 16]
  14. Marras TK, Chan CK. Use of guidelines in treating community‑acquired pneumonia. Chest 1998;113:1689‑94
  15. Capelastegui A, España PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I, et al. Improvement of process‑of‑care and outcomes after implementing a gui